Citadel Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-704,787
Closed -$1.11M 13455
2025
Q4
$2.18M Sell
704,787
-1,579,429
-69% -$4.51M ﹤0.01% 5742
2025
Q3
$6.01M Buy
2,284,216
+1,516,655
+198% +$3.34M ﹤0.01% 4025
2025
Q2
$944K Buy
767,561
+610,629
+389% +$666K ﹤0.01% 7230
2025
Q1
$173K Buy
156,932
+16,925
+12% +$19.6K ﹤0.01% 10654
2024
Q4
$127K Sell
140,007
-900,046
-87% -$771K ﹤0.01% 11113
2024
Q3
$1.03M Sell
1,040,053
-3,053,783
-75% -$2.94M ﹤0.01% 6816
2024
Q2
$3.69M Buy
4,093,836
+219,110
+6% +$164K ﹤0.01% 4241
2024
Q1
$4.57M Sell
3,874,726
-2,265,506
-37% -$2.49M ﹤0.01% 4083
2023
Q4
$5.6M Sell
6,140,232
-27,911
-0.5% -$20.6K ﹤0.01% 3626
2023
Q3
$5.14M Buy
6,168,143
+4,741,674
+332% +$5.46M ﹤0.01% 3604
2023
Q2
$1.71M Sell
1,426,469
-1,368,248
-49% -$1.7M ﹤0.01% 5438
2023
Q1
$3.52M Buy
+2,794,717
New +$5.35M ﹤0.01% 4385
2022
Q4
Sell
-731,264
Closed -$6.02M 15089
2022
Q3
$8.76M Sell
731,264
-1,551,585
-68% -$19.3M ﹤0.01% 2960
2022
Q2
$19.1M Buy
2,282,849
+138,538
+6% +$1.07M ﹤0.01% 1891
2022
Q1
$18.6M Buy
2,144,311
+268,560
+14% +$2.59M ﹤0.01% 2065
2021
Q4
$21.2M Buy
1,875,751
+287,800
+18% +$3.42M ﹤0.01% 1947
2021
Q3
$20M Buy
1,587,951
+1,572,150
+9,950% +$14.5M ﹤0.01% 1990
2021
Q2
$128K Sell
15,801
-564,995
-97% -$4.9M ﹤0.01% 12677
2021
Q1
$5.37M Sell
580,796
-189,962
-25% -$1.92M ﹤0.01% 4102
2020
Q4
$7.45M Buy
770,758
+691,286
+870% +$6.81M ﹤0.01% 3047
2020
Q3
$986K Buy
79,472
+33,286
+72% +$441K ﹤0.01% 6058
2020
Q2
$600K Sell
46,186
-268,266
-85% -$3.37M ﹤0.01% 6739
2020
Q1
$3.19M Buy
314,452
+272,828
+655% +$3.56M ﹤0.01% 3354
2019
Q4
$650K Sell
41,624
-881,320
-95% -$17.8M ﹤0.01% 6374
2019
Q3
$15.5M Sell
922,944
-3,978
-0.4% -$79.1K 0.01% 1725
2019
Q2
$20.6M Sell
926,922
-45,651
-5% -$873K 0.01% 1399
2019
Q1
$21.1M Buy
+972,573
New +$20.3M 0.01% 1295

Other funds holding GOSS